US FDA approves pancreatic enzyme replacement product Creon (PharmaBiz) The US Food and Drug Administration (FDA) has approved Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods.
ARYx Reports First Quarter 2009 Results and Earnings (Business Wire via Yahoo! Finance) FREMONT, Calif.----ARYx Therapeutics, Inc. today reported results of operations and provided an update on its products for the first quarter ended March 31, 2009.
Spherix Elects New Independent Director, and Elects Chairman of the Board (PR Newswire via Yahoo! Finance) Spherix Incorporated , an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that, on May 12, 2009, its Board of Directors elected a new, independent Director, Thomas B.